Jack Henry & Associates holds the cleaner structural position, with stability as the main driver and growth adding further support. West Pharmaceutical Services still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, West Pharmaceutical Services carries the stronger setup — intact trend against Jack Henry & Associates's broken trend. That leaves a split case: the structural lead stays with Jack Henry & Associates, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
The clearest separation starts in stability, but valuation adds another real layer to the result. The overall score gap is 15 points in favour of Jack Henry & Associates, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.
The strongest overlap appears in capital structure and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Jack Henry & Associates, Inc. looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where JKHY and WST each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The stability gap is very wide, with the stronger side looking materially steadier through time.
Earnings growth also leans toward WST, which keeps the score lead from reading as a full growth sweep.
The stability edge is decisive, but growth still pushes back — the result holds, but not without a real counterweight.
Break down the JKHY vs WST comparison across all dimensions with the full interactive tool.
Explore how JKHY and WST each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.